Suggestions
James Winokur
Chief Executive Officer, CitraChem; Board Member, Association of Cannabinoid Specialists (ACS)
James Winokur is an accomplished business executive and entrepreneur currently serving as the Chief Executive Officer of CitraChem Corp., a start-up life sciences company.12 CitraChem Corp. focuses on developing a patent-pending chemical synthesis process to create ultra-pure, cost-effective, single-molecule phytocannabinoids in a controlled laboratory environment.1
Professional Background
James has extensive experience in the cannabis industry:
- Founder of High Power Consulting, specializing in start-ups and small businesses, particularly in the cannabis sector1
- CEO of Berkshire Roots, a Massachusetts-based cannabis cultivation, production, and dispensary operator (December 2019 - April 2023)2
- SVP & General Manager, Product Group at MariMed Inc., a multi-state cannabis operator (December 2018 - November 2019)2
- Co-founder and CEO of CannaKorp, a company that developed a pod-based cannabis vaporizer home appliance (May 2014 - March 2019)2
Earlier Career
Before entering the cannabis industry, James held significant positions in other sectors:
- Senior Director of Marketing & Business Development for Global Support at PTC, contributing to sustaining $650 million in annual revenue2
- General Manager at Bedworks Inc., a furniture manufacturing and retail company2
- VP & General Manager at Culligan International, dealing with water treatment products and services2
Education
James holds the following degrees:
- MBA in Marketing and Operations from Boston College Carroll School of Management (2000-2002)2
- B.A. in Political Science from Boston College (1982-1986)2
Additional Roles
In addition to his primary role at CitraChem Corp., James serves on the Board of Directors for the Association of Cannabinoid Specialists (ACS), an international association of healthcare professionals focused on cannabinoid medicine.2 He contributes his expertise in business development, marketing, and operations to support ACS's mission of advancing cannabis medicine and patient care.
Highlights
Take the Win Cannabiz
(My short take below. For my full blog: https://lnkd.in/eMYf6eEP
You won Olympic gold but didn’t set a world record, are you disappointed?
I say “Take the Win” a lot in the cannabis industry. Now, I’m applying that to the possibility the DEA will accept the Health and Human Services recommendation to move cannabis from Schedule I to Schedule III. There have been many articles and posts within and outside the cannabis industry about whether that’s a good idea and the associated ramifications. In terms of ramifications, I’ll go with: we don’t know what we don’t know.
I say, “Take the Win” now because rescheduling to Schedule III is a big step in a positive direction. Is there any historical reference we could use to think changes could happen over time? How about the end of Prohibition? While not a perfectly analogous set of circumstances, it’s a close cousin. The short story is that Franklin Roosevelt campaigned in his first Presidential bid to change prohibition. Once elected, a bill was written—the Cullen-Harrison Act— “to legalize beer with 3.2 percent alcohol content and light wines”.1 That was the original law that technically ended Prohibition, but it was not a free-for-all. And other steps followed over time.
My hope is that rescheduling further opens the door for Congress to pass the SAFER Banking Act; encourages more pharmaceutical companies to do clinical research so we really understand the benefits and risks to very specific strains, terpenes, forms of usage and drug interactions; and leads clinicians to consider cannabis as a legitimate alternative to other prescription medications or find the combination of the two is best. For consumers, I hope they place more confidence in products sold under federal and state regulations which should be safer (unadulterated) and more effective because they follow specific criteria and formulations that can be audited—even for the recreational user.
So, should we Take the Win with rescheduling or yell at the sky and pump our fists that it’s not enough?
1 Prohibition Museum, “The Repeal of Prohibition”
#scheduleIII, #ACS, #cannabis, #safebanking, #cannabisresearch
Looking forward to Sunday night’s newest in CNN’s “Weed” series. A portion of an article posted on CNN today below…check out Dr. Gupta’s epiphany…
Dr. Sanjay Gupta: Cannabis is having a senior moment
(CNN) — Prior to filming our first documentary on cannabis a decade ago, I was highly skeptical about its use as a medicine. I had even written a story for Time magazine a few years earlier to make the case that the evidence simply wasn’t there.
At the end of our time together, Ken asked me if I would ever recommend cannabis for my own parents, who are in their late 70s;
But, in the end, there is no question that, especially for those nuisances of aging, cannabis could provide a relief they had been hard-pressed to find with the medications they were typically prescribed.
My answer to his question was “yes.”
And I guess that may be the biggest thing that has changed over the past 10 years. I would’ve never imagined a time when I would openly recommend cannabis to my own parents – or a time they would openly consider taking it.
#associationofcannabinoidspecialists #drjordantishler #cannabismedicine
